ENTERA BIO LTD. Total Liabilities
ENTERA BIO LTD. (ENTX) had Total Liabilities of $12.21 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities
us-gaap:Liabilities · last filed 2026-08-07
- 2026-06-30: Liabilities $12.21M.
- 2026-03-31: Liabilities $2.44M.
- 2025-12-31: Liabilities $2.89M.
- 2025-09-30: Liabilities $2.17M.
| Period end | Liabilities |
|---|---|
| 2026-06-30 | $12.21M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $2.44M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $2.89M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $2.17M 10-Q · filed 2025-11-14 |
| 2025-06-30 | $2.41M 10-Q · filed 2025-08-08 |
| 2025-03-31 | $2.22M 10-Q · filed 2025-05-09 |
| 2024-12-31 | $1.31M 10-K · filed 2026-03-27 |
| 2024-09-30 | $1.29M 10-Q · filed 2024-11-08 |
| 2024-06-30 | $1.50M 10-Q · filed 2024-08-09 |
| 2024-03-31 | $1.38M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $1.38M 10-K · filed 2025-03-28 |
| 2023-09-30 | $2.33M 10-Q · filed 2023-11-14 |
| 2023-06-30 | $2.21M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $1.53M 10-Q · filed 2023-05-05 |
| 2022-12-31 | $1.37M 10-K · filed 2024-03-08 |
| 2022-09-30 | $1.23M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.82M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.57M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $3.42M 10-K · filed 2023-03-31 |
| 2020-12-31 | $2.21M 10-K · filed 2022-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B | |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |